Literature DB >> 8411209

Sequence comparison and mutational analysis of elements that may be involved in the regulation of DNA synthesis in HIV-1.

O Hungnes1, K Jønsrud, E Tjøtta, B Grinde.   

Abstract

The large number of sequenced clones of HIV-1 and related viruses made it possible to indicate conserved elements with potential regulatory or structural functions. Such analysis was combined with directed mutagenesis in order to investigate the importance of elements that may influence the initiation of plus-strand DNA synthesis. The main site for plus-strand initiation is a polypurine tract near the 3' end of the viral RNA (the 3' PPT). An exact copy of this PPT is located in the middle of the genome (the internal PPT). Upstream from the internal PPT there is an inverted repeat. Mutants designed to upset the internal PPT (i.e., purine to pyrimidine changes), as well as mutants designed to abolish the potential stem-loop formation (changes around the internal PPT or in the upstream inverted repeat) both resulted in viruses with a reduced ability to replicate. Upsetting the stem-loop formation was, however, less harmful than changing the polypurine nature of the PPT. Changing a conserved T on the 3' side of the PPT to a C did not affect the phenotype.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8411209     DOI: 10.1007/bf02407356

Source DB:  PubMed          Journal:  J Mol Evol        ISSN: 0022-2844            Impact factor:   2.395


  21 in total

1.  Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay.

Authors:  S Harada; Y Koyanagi; N Yamamoto
Journal:  Science       Date:  1985-08-09       Impact factor: 47.728

2.  The "megaprimer" method of site-directed mutagenesis.

Authors:  G Sarkar; S S Sommer
Journal:  Biotechniques       Date:  1990-04       Impact factor: 1.993

3.  Use of eukaryotic expression technology in the functional analysis of cloned genes.

Authors:  B R Cullen
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

4.  Discontinuities in the DNA synthesized by an avian retrovirus.

Authors:  J M Taylor; A Cywinski; J K Smith
Journal:  J Virol       Date:  1983-12       Impact factor: 5.103

5.  Plus-strand priming by Moloney murine leukemia virus. The sequence features important for cleavage by RNase H.

Authors:  A J Rattray; J J Champoux
Journal:  J Mol Biol       Date:  1989-08-05       Impact factor: 5.469

6.  A second origin of DNA plus-strand synthesis is required for optimal human immunodeficiency virus replication.

Authors:  P Charneau; M Alizon; F Clavel
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

7.  Processing of the primer for plus strand DNA synthesis by human immunodeficiency virus 1 reverse transcriptase.

Authors:  H E Huber; C C Richardson
Journal:  J Biol Chem       Date:  1990-06-25       Impact factor: 5.157

8.  Mutations in the central polypurine tract of HIV-1 result in delayed replication.

Authors:  O Hungnes; E Tjøtta; B Grinde
Journal:  Virology       Date:  1992-09       Impact factor: 3.616

9.  Polypurine tract adjacent to the U3 region of the Rous sarcoma virus genome provides a cis-acting function.

Authors:  J Sorge; S H Hughes
Journal:  J Virol       Date:  1982-08       Impact factor: 5.103

10.  Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions.

Authors:  A Lever; H Gottlinger; W Haseltine; J Sodroski
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

View more
  2 in total

1.  Athila4 of Arabidopsis and Calypso of soybean define a lineage of endogenous plant retroviruses.

Authors:  David A Wright; Daniel F Voytas
Journal:  Genome Res       Date:  2002-01       Impact factor: 9.043

2.  Using pyrrolo-deoxycytosine to probe RNA/DNA hybrids containing the human immunodeficiency virus type-1 3' polypurine tract.

Authors:  Chandravanu Dash; Jason W Rausch; Stuart F J Le Grice
Journal:  Nucleic Acids Res       Date:  2004-03-05       Impact factor: 16.971

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.